GEODE CAPITAL MANAGEMENT, LLC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 38 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$9,628
-44.1%
50,6780.0%0.00%
Q1 2023$17,230
+114766.7%
50,6780.0%0.00%
Q4 2022$15
-99.9%
50,6780.0%0.00%
Q3 2022$21,000
-4.5%
50,6780.0%0.00%
Q2 2022$22,000
-65.1%
50,6780.0%0.00%
Q1 2022$63,000
-3.1%
50,6780.0%0.00%
Q4 2021$65,000
-37.5%
50,678
-0.1%
0.00%
Q3 2021$104,000
+60.0%
50,731
+21.8%
0.00%
Q2 2021$65,000
-90.3%
41,645
-86.3%
0.00%
Q1 2021$672,000
-9.6%
303,055
+1.1%
0.00%
Q4 2020$743,000
+1.6%
299,793
+0.9%
0.00%
Q3 2020$731,000
-27.7%
297,236
+4.4%
0.00%
Q2 2020$1,011,000
+942.3%
284,830
+584.8%
0.00%
Q1 2020$97,000
-14.9%
41,592
-20.5%
0.00%
Q4 2019$114,000
+137.5%
52,344
+100.0%
0.00%
Q3 2019$48,000
+23.1%
26,172
-3.1%
0.00%
Q2 2019$39,000
-86.7%
27,005
-81.9%
0.00%
Q1 2019$294,000
-16.0%
149,354
-44.3%
0.00%
Q4 2018$350,000
+17.8%
268,042
+121.7%
0.00%
Q3 2018$297,000
-19.3%
120,918
+10.1%
0.00%
Q2 2018$368,000
-3.7%
109,786
+21.3%
0.00%
Q1 2018$382,000
+29.9%
90,502
+1.5%
0.00%
Q4 2017$294,000
-5.2%
89,196
+9.9%
0.00%
Q3 2017$310,000
-4.9%
81,175
+9.5%
0.00%
Q2 2017$326,000
+323.4%
74,107
+248.2%
0.00%
Q1 2017$77,000
+40.0%
21,281
+2.2%
0.00%
Q4 2016$55,000
+19.6%
20,813
+45.5%
0.00%
Q3 2016$46,000
-2.1%
14,309
+0.5%
0.00%
Q2 2016$47,000
+38.2%
14,2310.0%0.00%
Q1 2016$34,000
-26.1%
14,231
-0.5%
0.00%
Q4 2015$46,00014,3090.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2022
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders